Investigation of cortical cholinergic projection integrity in relation to longitudinal cognitive performance in Parkinson's disease

We found strong evidence for a modest association between baseline cortical cholinergic integrity and cognition in PD. This suggests that the composite measure of cortical cholinergic projection integrity used in this analysis was consistently related to cognitive performance across assessment timepoints but there was no evidence baseline integrity predicted differential rates of cognitive decline. Combining measures from additional components of the brain cholinergic system, or from other neurotransmitter systems, may provide greater insight into cognitive trajectories in PD.

Authors

Institutions

Publication Details

Journal
Alzheimer s & Dementia
Published
2025-12-01
DOI
https://doi.org/10.1002/alz70856_105399
Primary Topic
Parkinson's Disease Mechanisms and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Investigation of cortical cholinergic projection integrity in relation to longitudinal cognitive performance in Parkinson's disease

Tim Anderson, Ian J. Kirk, John C. Dalrymple‐Alford, Nicola M. Slater et al.
Alzheimer s & Dementia
Parkinson's Disease Mechanisms and Treatments
article

Investigation of cortical cholinergic projection integrity in relation to longitudinal cognitive performance in Parkinson's disease

Tim Anderson, Ian J. Kirk, John C. Dalrymple‐Alford, Nicola M. Slater, Tracy Melzer, Ross Keenan, Kyla‐Louise Horne, Daniel J Myall, Campbell J Le Heron, Wassilios G Meissner
article en

Abstract

We found strong evidence for a modest association between baseline cortical cholinergic integrity and cognition in PD. This suggests that the composite measure of cortical cholinergic projection integrity used in this analysis was consistently related to cognitive performance across assessment timepoints but there was no evidence baseline integrity predicted differential rates of cognitive decline. Combining measures from additional components of the brain cholinergic system, or from other neurotransmitter systems, may provide greater insight into cognitive trajectories in PD.

Alzheimer s & DementiaVol. 21(S2)
Université de Bordeaux (FR), University of Auckland (NZ), University of Canterbury (NZ), Christchurch Hospital (NZ), Pacific Radiology (New Zealand) (NZ), New Zealand Brain Research Institute (NZ), University of Otago (NZ)
Openalex Percentile: Top 29%
Parkinson's Disease Mechanisms and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.